Clinical Efficacy and cytokine release syndrome (CRS) risk of CD3 Bispecifics in prostate cancer

Leveraging in vitro data from novel drug candidates to prioritize antibody combinations in autoimmune disease using a QSP model of IBD

QSP model to predict clinical PK/PD of siRNA therapeutics and learnings from model development

QSP Platform for Predicting Alternate Priming Dose, Efficacy, and CRS Incidence in CD3 Bispecifics for STEAP1 Prostate Cancer

A quantitative systems pharmacology (QSP) model framework for combined clinical efficacy and hematological toxicity predictions for antibody-drug conjugates

DEVELOPMENT OF QSP PLATFORM MODEL FOR PREDICTING ALTERNATE PRIMING DOSE

A comprehensive multi-scale in silico approach for predicting antibody-drug conjugate clinical efficacy across oncological indications

A quantitative systems pharmacology (QSP) model for predicting the efficacy

CLINICAL DOSE PREDICTION FOR CHIMERIC ANTIGEN RECEPTOR

Development of Immuno-Oncology (IO) QSP Platform

QSP Model of Rheumatoid Arthritis

Development of mPBPK-target engagement model